| Gene symbol | tk |
| GTO ID | GTC3869 |
| Trial ID | NCT06391918 |
| Disease | Solid Tumor |
| Altered gene | tk |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | GEN2 |
| Co-treatment | Valganciclovir |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Phase 1 Study of GEN2 in Adult Patients With Locally Advanced or Metastatic Solid Tumor Malignancies |
| Year | 2024 |
| Country | United States |
| Company sponsor | GenVivo, Inc. |
| Other ID(s) | Protocol GVO-1102 |
| Cohort 1 | |||||||
|
|||||||